The role of oxidative stress in the pathophysiology of gestational diabetes mellitus

Antioxidants and Redox Signaling

Volumn 15, Issue 12, 2011, Pages 3061-3100

  Lappas, Martha ^a,b   Hiden, Ursula ^c   Desoye, Gernot ^c   Froehlich, Julia ^c   Mouzon, Sylvie Hauguel De ^d   Jawerbaum, Alicia ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BUTYLCRESOL; CYTOKINE; FLAVONOID; FOLIC ACID; HEXOSAMINE; I KAPPA B; METALLOPROTEINASE; POLYOL; PROTEIN KINASE C; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; TRANSITION ELEMENT; XANTHINE OXIDASE;

AMINO ACID TRANSPORT; APOPTOSIS; CLINICAL PATHWAY; DECIDUALIZATION; EMBRYOPATHY; ENDOCRINE DISEASE; ENDOTHELIAL DYSFUNCTION; FATTY ACID TRANSPORT; FETUS MALFORMATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERTENSION; INCIDENCE; LABOR; LIPID PEROXIDATION; MITOCHONDRION; NITRATIVE STRESS; OBESITY; ORGANOGENESIS; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA; PLACENTAL TRANSFER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RENOVASCULAR DISEASE; REVIEW; SEDENTARY LIFESTYLE; TROPHOBLAST; UMBILICAL CORD; UTERINE CERVIX RIPENING; WEIGHT GAIN;

ANTIOXIDANTS; DIABETES, GESTATIONAL; FEMALE; FETUS; HUMANS; OXIDATIVE STRESS; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 80054087219     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3765     Document Type: Review

References (389)

1. Afkhami-Ardekani M and Rashidi M. Iron status in women with and without gestational diabetes mellitus. J Diabetes Complications 23: 194-198, 2009.
2. Agarwal A, Gupta S, and Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3: 28, 2005.
3. AguirreV,Uchida T,Yenush L,Davis R, andWhiteMF. The c-JunNH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem275: 9047-9054, 2000.
4. Aisemberg J, Vercelli C, Wolfson M, Salazar AI, Osycka-Salut C, Billi S, Ribeiro ML, Farina M, and Franchi AM. Inflammatory agents involved in septic miscarriage. Neuroimmunomodulation 17: 150-152, 2010.
5. Al Ghafli MH, Padmanabhan R, Kataya HH, and Berg B. Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses. Mol Cell Biochem 261: 123-135, 2004.
6. Allen VM, Armson BA, Wilson RD, Blight C, Gagnon A, Johnson JA, Langlois S, SummersA,Wyatt P, Farine D, Crane J, DelisleMF, Keenan-Lindsay L, Morin V, Schneider CE, and Van Aerde J; Society of Obstetricians and Gynecologists of Canada. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can 29: 927-944, 2007.
7. Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A, and Stamatelopoulos SF. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21: 2111-2115, 1998.
8. Arts IC and Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81: 317S-325S, 2005.
9. Augustin R. The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life 62: 315-333, 2010.
10. Avignon A and Sultan A. PKC-B inhibition: a new therapeutic approach for diabetic complications? Diabetes Metab 32: 205-213, 2006.
11. Babawale MO, Lovat S, Mayhew TM, Lammiman MJ, James DK, and Leach L. Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia 43: 1185-1196, 2000.
12. Ban CR and Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manage 4: 575-596, 2008.
13. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, and Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 Suppl 2: S112-S119, 2007.
14. Barter PJ and Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis 121: 1-12, 1996.
15. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, and De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105: 816-822, 2002.
16. Basta G, Schmidt AM, and De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63: 582-592, 2004.
17. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, and Hauguel-de Mouzon S. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 19: 476-482, 2011.
18. Basuroy S, Bhattacharya S, Leffler CW, and Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol 296: C422-C432, 2009.
19. Bellamy L, Casas JP, Hingorani AD, and Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373: 1773-1779, 2009.
20. Biri A, Onan A, DevrimE, Babacan F, KavutcuM, and Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27: 327-332, 2006.
21. Bitsanis D, Ghebremeskel K, Moodley T, Crawford MA, and Djahanbakhch O. Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 41: 341-346, 2006.
22. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J, and Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43: 675-684, 1999.
23. Bo S, Lezo A, Menato G, Gallo ML, Bardelli C, Signorile A, Berutti C, Massobrio M, and Pagano GF. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition 21: 186-191, 2005.
24. Bo S, Menato G, Villois P, Gambino R, Cassader M, Cotrino I, and Cavallo-Perin P. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol 201, 158.e1-6, 2009.
25. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
26. Bohlender JM, Franke S, Stein G, and Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 289: F645-F659, 2005.
27. Boisvert MR, Koski KG, and Skinner CD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem 82: 1133-1137, 2010.
28. Borrego-Diaz E, Rosales JC, Proverbio T, Teppa-Garran A, Andaluz R, Abad C, Marin R, and Proverbio F. Effect of placental hypoxia on the plasma membrane Ca-ATPase (PMCA) activity and the level of lipid peroxidation of syncytiotrophoblast and red blood cell ghosts. Placenta 29: 44-50, 2008.
29. Borriello A, Cucciolla V, Della Ragione F, and Galletti P. Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20: 618-625, 2010.
30. Bouche C, Serdy S, Kahn CR, and Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev 25: 807-830, 2004.
31. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
32. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86: 989-993, 2001.
33. Buchanan TA and Xiang AH. Gestational diabetes mellitus. J Clin Invest 115: 485-491, 2005.
34. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, Goico J, Ochoa C, and Azen SP. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 49: 782-788, 2000.
35. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, Fairchild T, and Buhimschi CS. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 196: 181.e1-13, 2007.
36. Burns J, Yokota T, Ashihara H, Lean ME, and Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 50: 3337-3340, 2002.
37. Butte NF, Hsu HW, Thotathuchery M, Wong WW, Khoury J, and Reeds P. Protein metabolism in insulin-treated gestational diabetes. Diabetes Care 22: 806-811, 1999.
38. Camuzcuoglu H, Toy H, Cakir H, Celik H, and Erel O. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. J Womens Health 18: 1435-1439, 2009.
39. Cani PD. Gut microbiota and pregnancy, a matter of inner life. Br J Nutr 101: 1579-1580, 2009.
40. Capobianco E, Jawerbaum A, Romanini MC, White V, Pustovrh C, Higa R, Martinez N, Mugnaini MT, Sonez C, and Gonzalez E. 15-Deoxy-Delta(12,14)- prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism. Reprod Fertil Dev 17: 423-433, 2005.
41. Carew TE. Role of biologically modified low-density lipoprotein in atherosclerosis. Am J Cardiol 64: 18G-22G, 1989.
42. Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K, Shofer JB, Heckbert SR, Boyko EJ, Fujimoto WY, and Kahn SE. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 29: 2078-2083, 2006.
43. Casanello P, Escudero C, and Sobrevia L. Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol 5: 69-84, 2007.
44. Casanueva E and Viteri FE. Iron and oxidative stress in pregnancy. J Nutr 133: 1700S-1708S, 2003.
45. Catalano PM, Drago NM, and Amini SB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol 172: 1464-1470, 1995.
46. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, and Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 90: 1303-1313, 2009.
47. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, and Friedman JE. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 282: E522-E533, 2002.
48. Catalano PM, Tyzbir ED, Wolfe RR, Roman NM, Amini SB, and Sims EA. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol 167: 913-919, 1992.
49. Caughey AB, Cheng YW, Stotland NE, Washington AE, and Escobar GJ. Maternal and paternal race/ethnicity are both associated with gestational diabetes. Am J Obstet Gynecol 202: 616.e1-5, 2010.
50. Cavanal Mde F, Gomes GN, Forti AL, Rocha SO, Franco Mdo C, Fortes ZB, and Gil FZ. The influence of L-arginine on blood pressure, vascular nitric oxide and renal morphometry in the offspring from diabetic mothers. Pediatr Res 62: 145-150, 2007.
51. Cederberg J, Basu S, and Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44: 766-774, 2001.
52. Cederberg J and Eriksson UJ. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Defects Res A Clin Mol Teratol 73: 498-505, 2005.
53. Cederberg J, Galli J, Luthman H, and Eriksson UJ. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes 49: 101-107, 2000.
54. Chang TI, Horal M, Jain SK, Wang F, Patel R, and Loeken MR. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46: 538-545, 2003.
55. Chappell JH Jr., Wang XD, and Loeken MR. Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis 14: 1472-1483, 2009.
56. Chaudhari L, Tandon OP, Vaney N, and Agarwal N. Lipid peroxidation and antioxidant enzymes in gestational diabetics. Indian J Physiol Pharmacol 47: 441-446, 2003.
57. Chekir C, Nakatsuka M, Noguchi S, Konishi H, Kamada Y, Sasaki A, Hao L, and Hiramatsu Y. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 27: 225-233, 2006.
58. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, and Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 30: 2070-2076, 2007.
59. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, and Burton GJ. Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170: 1511-1520, 2007.
60. Cindrova-Davies T, Yung HW, Johns J, Spasic-Boskovic O, Korolchuk S, Jauniaux E, Burton GJ, and Charnock-Jones DS. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 171: 1168-1179, 2007.
61. Closs EI, Basha FZ, Habermeier A, and Forstermann U. Interference of L-arginine analogues with L-arginine transport mediated by the y + carrier hCAT-2B. Nitric Oxide 1: 65-73, 1997.
62. Colomiere M, Permezel M, and Lappas M. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol 44: 213-223, 2010.
63. Colomiere M, Permezel M, Riley C, Desoye G, and Lappas M. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160: 567-578, 2009.
64. Conrad KP and Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 257: R847-R853, 1989.
65. Cooke CLM, Brockelsby JC, Baker PN, and Davidge ST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 22: 173-184, 2003.
66. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, and Reece EA. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199: 237.e1-9, 2008.
67. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, and Rice GE. Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18: 921-927, 2001.
68. Coughlan MT, Permezel M, Georgiou HM, and Rice GE. Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J Clin Endocrinol Metab 89: 3585-3594, 2004.
69. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, and Rice GE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25: 78-84, 2004.
70. Coustan DR, Lowe LP, and Metzger BE. The hyperglycemia and adverse pregnancy outcome (HAPO) study: can we use the results as a basis for change? J Matern Fetal Neonatal Med 23: 204-209, 2010.
71. Cui XL, Brockman D, Campos B, and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27: 422-431, 2006.
72. Damasceno DC, Volpato GT, de Mattos Paranhos Calderon I, and Cunha Rudge MV. Oxidative stress and diabetes in pregnant rats. Anim Reprod Sci 72: 235-244, 2002.
73. Davari-Tanha F, Khan-Mohamadi F, Kaveh M, and Shariat M. Homocysteine in gestational diabetes and normal pregnancy plus effects of folic acid. Iran J Public Health 37: 118-126, 2008.
74. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, and Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31: 361-362, 2008.
75. Dennery PA. Effects of oxidative stress on embryonic development. Birth Defects Res C Embryo Today 81: 155-162, 2007.
76. Desoye G and Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30 Suppl 2: S120-S126, 2007.
77. Desoye G, Hofmann HH, and Weiss PA. Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 35: 45-55, 1992.
78. Desoye G and Shafrir E. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med 15: 505-682, 1994.
79. Desoye G and Shafrir E. The human placenta in diabetic pregnancy. Diabetes Rev 4: 70-89, 1996.
80. Dey P, Gupta P, Acharya NK, Rao SN, Ray S, Chakrabarty S, Ramprasad S, Kurian TA, Mawroh A, Kundu A, Bhaktha G, Joseph CP, Kumar P, Rai L, and Rao A. Antioxidants and lipid peroxidation in gestational diabetes-a preliminary study. Indian J Physiol Pharmacol 52: 149-156, 2008.
81. Di Iulio JL, Gude NM, King RG, Li CG, Rand MJ, and Brennecke SP. Human placental nitric oxide synthase activity is not altered in diabetes. Clin Sci (Lond) 97: 123-128, 1999.
82. Diderholm B, Stridsberg M, Ewald U, Lindeberg-Norden S, and Gustafsson J. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG 112: 713-718, 2005.
83. Ector BJ, Magee JB, Hegwood CP, and Coign MJ. Resveratrol concentration in muscadine berries, juice, pomace, purees, seeds, and wines. Am J Enol Vitic 47: 57-62, 1996.
84. El-Remessy AB, Al-Shabrawey M, Platt DH, Bartoli M, Behzadian MA, Ghaly N, Tsai N, Motamed K, and Caldwell RB. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J 21: 2528-2539, 2007.
85. Ericsson A, Hamark B, Powell TL, and Jansson T. Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placenta. Hum Reprod 20: 521-530, 2005.
86. Eriksson UJ. Congenital anomalies in diabetic pregnancy. Semin Fetal Neonatal Med 14: 85-93, 2009.
87. Eriksson UJ, Cederberg J, and Wentzel P. Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev Endocr Metab Disord 4: 79-93, 2003.
88. Eriksson UJ and Siman CM. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45: 1497-1502, 1996.
89. Escudero C and Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 29: 469-483, 2008.
90. Ethier-Chiasson M, Forest JC, Giguere Y, Masse A, Marseille-Tremblay C, Levy E, and Lafond J. Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction 136: 491-502, 2008.
91. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
92. Fan E, Zhang L, Jiang S, and Bai Y. Beneficial effects of resveratrol on atherosclerosis. J Med Food 11: 610-614, 2008.
93. Farias M, Puebla C, Westermeier F, Jo MJ, Pastor-Anglada M, Casanello P, and Sobrevia L. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res 86: 45-54, 2010.
94. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, and Stepan H. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens 26: 1824-1828, 2008.
95. Feng Q, Song W, Lu X, Hamilton JA, Lei M, Peng T, and Yee SP. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106: 873-879, 2002.
96. Fetita LS, Sobngwi E, Serradas P, Calvo F, and Gautier JF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab 91: 3718-3724, 2006.
97. Figueroa R, Martinez E, Fayngersh RP, Tejani N, Mohazzab HK, and Wolin MS. Alterations in relaxation to lactate and H(2)O(2) in human placental vessels from gestational diabetic pregnancies. Am J Physiol Heart Circ Physiol 278: H706-H713, 2000.
98. Forbes JM, Coughlan MT, and Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454, 2008.
99. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, and Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48: 1807-1814, 1999.
100. Friedman JE, Kirwan JP, Jing M, Presley L, and Catalano PM. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes 57: 606-613, 2008.
101. Fukuen S, Iwaki M, Yasui A, Makishima M, Matsuda M, and Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. J Biol Chem 280: 23653-23659, 2005.
102. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
103. Gao L, Liu WH, Luan NN, Feng C, and Shang T. Correlation between the expression of high mobility group box 1 and receptor for advanced glycation end products and the onset of pre-eclampsia. Zhonghua Fu Chan Ke Za Zhi 43: 746-750, 2008.
104. Gao L and Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20, 2009.
105. Gao X, Zhang H, Schmidt AM, and Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol 295: H491-H498, 2008.
106. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277: 48115-48121, 2002.
107. Gareskog M, Eriksson UJ, and Wentzel P. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res A Clin Mol Teratol 76: 483-490, 2006.
108. Garris DR. Effects of diabetes on uterine condition, decidualization, vascularization, and corpus luteum function in the pseudopregnant rat. Endocrinology 122: 665-672, 1988.
109. Garvey WT, Maianu L, Hancock JA, Golichowski AM, and Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41: 465-475, 1992.
110. Ge X, Yu Q, Qi W, Shi X, and Zhai Q. Chronic insulin treatment causes insulin resistance in 3T3-L1 adipocytes through oxidative stress. Free Radic Res 42: 582-591, 2008.
111. Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, and Rice GE. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45: 157-165, 2008.
112. Gerber RT, Holemans K, O'Brien-Coker I, Mallet AI, van Bree R, Van Assche FA, and Poston L. Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidation. Am J Obstet Gynecol 183: 1035-1040, 2000.
113. Getahun D, Nath C, Ananth CV, Chavez MR, and Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 198: 525.e1-5, 2008.
114. Gloire G, Legrand-Poels S, and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
115. Goh SY and Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152, 2008.
116. Gonzalez E, Jawerbaum A, Novaro V, Sinner D, and Gimeno M. Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat. Prostaglandins Leukot Essent Fatty Acids 59: 299-304, 1998.
117. Gonzalez M, Gallardo V, Rodriguez N, Salomon C, Westermeier F, Guzman-Gutierrez E, Abarzua F, Leiva A, Casanello P, and Sobrevia L. Insulin-stimulated L-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J Cell Physiol 2011 [Epub ahead of print]; DOI:10.1002/jcp.22635.
118. Gorovits N, Cui L, Busik JV, Ranalletta M, Hauguel de-Mouzon S, and Charron MJ. Regulation of hepatic GLUT8 expression in normal and diabetic models. Endocrinology 144: 1703-1711, 2003.
119. Grissa O, Ategbo JM, Yessoufou A, Tabka Z, Miled A, Jerbi M, Dramane KL, Moutairou K, Prost J, Hichami A, and Khan NA. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl Res 150: 164-171, 2007.
120. Grossin N, Wautier MP, and Wautier JL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 46: 63-72, 2009.
121. Gude NM, Stevenson JL, Rogers S, Best JD, Kalionis B, Huisman MA, Erwich JJ, Timmer A, and King RG. GLUT12 expression in human placenta in first trimester and term. Placenta 24: 566-570, 2003.
122. Guilloteau P, Zabielski R, Hammon HM, and Metges CC. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol 60 Suppl 3: 17-35, 2009.
123. Gupte S, Labinskyy N, Gupte R, Csiszar A, Ungvari Z, and Edwards JG. Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM. PLoS One 5: e11800, 2010.
124. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, and Groner Y. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173: 1036-1041, 1995.
125. Haggarty P. Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr 58: 1559-1570, 2004.
126. Halliwell B and Gutteridge JMC. (Eds). Free Radicals in Biology and Medicine, 4th edition. Oxford, NY: Oxford University Press, 2007.
127. Hannemann MM, Liddell WG, Shore AC, Clark PM, and Tooke JE. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 39: 311-319, 2002.
128. Harris LK,McCormick J, Cartwright JE,Whitley GS, and Dash PR. S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp Cell Res 314: 1765-1776, 2008.
129. Harris MI. Gestational diabetes may represent discovery of preexisting glucose intolerance. Diabetes Care 11: 402-411, 1988.
130. Hauguel-de Mouzon S, Challier JC, Kacemi A, Cauzac M, Malek A, and Girard J. The GLUT3 glucose transporter isoform is differentially expressed within human placental cell types. J Clin Endocrinol Metab 82: 2689-2694, 1997.
131. Hay WW, Jr. Glucose metabolism in the fetal-placental unit. In: Principles of Perinatal-Neonatal Metabolism, edited by Cowett R. New York: Springer, 1998, pp. 337-367.
132. Herman JB and Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet 2: 240-243, 1982.
133. Herrera E. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development-a review. Placenta 23 Suppl A: S9-S19, 2002.
134. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 19: 43-55, 2002.
135. Herring SJ and Oken E. Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle? Curr Diab Rep 11: 20-27, 2011.
136. Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, and Desoye G. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-a levels. Diabetes 57: 150-157, 2008.
137. Higa R, Gonzalez E, Pustovrh MC, White V, Capobianco E, Martinez N, and Jawerbaum A. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis. Mol Hum Reprod 13: 103-110, 2007.
138. Higa R, White V, Martinez N, Kurtz M, Capobianco E, and Jawerbaum A. Safflower and olive oil dietary treatments rescue aberrant embryonic arachidonic acid and nitric oxide metabolism and prevent diabetic embryopathy in rats. Mol Hum Reprod 16: 286-295, 2010.
139. Hockett PK, Emery SC, Hansen L, and Masliah E. Evidence of oxidative stress in the brains of fetuses with CNS anomalies and islet cell hyperplasia. Pediatr Dev Pathol 7: 370-379, 2004.
140. Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, and Lappas M. Peroxisome proliferatoractivated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31: 222-229, 2010.
141. Holemans K, Gerber RT, Meurrens K, De Clerck F, Poston L, and Van Assche FA. Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 42: 81-89, 1999.
142. Horvath EM, Magenheim R, Kugler E, Vacz G, Szigethy A, Levardi F, Kollai M, Szabo C, and Lacza Z. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia 52: 1935-1943, 2009.
143. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
144. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
145. Innis SM. Essential fatty acid transfer and fetal development. Placenta 26 Suppl A: S70-S75, 2005.
146. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, Handy DE, Loscalzo J, Apstein CS, and Liao R. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res 93: e9-e16, 2003.
147. Jain SK, McVie R, and Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 23: 1389-1394, 2000.
148. Jaiswal M, LaRusso NF, and Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281: G626-G634, 2001.
149. Jansson T, Cetin I, Powell TL, Desoye G, Radaelli T, Ericsson A, and Sibley CP. Placental transport and metabolism in fetal overgrowth-a workshop report. Placenta 27 Suppl A: S109-S113, 2006.
150. Jansson T, Ekstrand Y, Bjorn C, Wennergren M, and Powell TL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 51: 2214-2219, 2002.
151. Jansson T and Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113: 1-13, 2007.
152. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, and Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond) 119: 123-129, 2010.
153. Jawerbaum A, Capobianco E, Pustovrh C, White V, Baier M, Salzberg S, Pesaresi M, and Gonzalez E. Influence of peroxisome proliferator-activated receptor c activation by its endogenous ligand 15-deoxy D12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod 10: 671-676, 2004.
154. Jawerbaum A and Gonzalez E. The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des 11: 1327-1342, 2005.
155. Jawerbaum A and Gonzalez E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem 13: 2127-2138, 2006.
156. Jawerbaum A, Higa R, White V, Capobianco E, Pustovrh C, Sinner D, Martinez N, and Gonzalez E. Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis. Reproduction 130: 695-703, 2005.
157. Jawerbaum A, Sinner D, White V, Pustovrh C, Capobianco E, and Gonzalez E. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. Reproduction 124: 625-631, 2002.
158. Jawerbaum A and White V. Animal models in diabetes and pregnancy. Endocr Rev 31: 680-701, 2010.
159. Jirkovska M, Kubinova L, Janacek J, Moravcova M, Krejci V, and Karen P. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res 39: 268-278, 2002.
160. Jones CJ and Desoye G. Glycogen distribution in the capillaries of the placental villus in normal, overt and gestational diabetic pregnancy. Placenta 14: 505-517, 1993.
161. Jones KL, de Kretser DM, Patella S, and Phillips DJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 225: 119-125, 2004.
162. Jones RH and Ozanne SE. Intra-uterine origins of type 2 diabetes. Arch Physiol Biochem 113: 25-29, 2007.
163. Kamath U, Rao G, Raghothama C, Rai L, and Rao P. Erythrocyte indicators of oxidative stress in gestational diabetes. Acta Paediatr 87: 676-679, 1998.
164. Kasapinovic S, McCallum GP, Wiley MJ, and Wells PG. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice. Free Radic Biol Med 37: 1703-1711, 2004.
165. Katsuyama K, Shichiri M, Marumo F, and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vasc Biol 18: 1796-1802, 1998.
166. Kaufmann P, Black S, and Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69: 1-7, 2003.
167. Kautzky-Willer A, Fasching P, Jilma B, Waldhausl W, and Wagner OF. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 82: 4117-4121, 1997.
168. Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, and Waldhausl W. Increased plasma leptin in gestational diabetes. Diabetologia 44: 164-172, 2001.
169. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, Weich H, Whittle M, and Ahmed A. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Lab Invest 79: 151-170, 1999.
170. Kharb S. Lipid peroxidation in pregnancy with preeclampsia and diabetes. Gynecol Obstet Invest 50: 113-116, 2000.
171. Kharb S. Ascorbic acid and uric acid levels in gestational diabetes mellitus. J Obstet Gynecol India 27: 401-402, 2007.
172. Khullar S, Greenwood SL, McCord N, Glazier JD, and Ayuk PT. Nitric oxide and superoxide impair human placental amino acid uptake and increase Na + permeability: implications for fetal growth. Free Radic Biol Med 36: 271-277, 2004.
173. Kilinc M, Guven M, Ezer M, Ertas I, and Coskun A. Evaluation of serum selenium levels in Turkish women with gestational diabetes mellitus, glucose intolerants, and normal controls. Biol Trace Elem Res 123: 35-40, 2008.
174. Kim YM, Bombeck CA, and Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84: 253-256, 1999.
175. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, and Kinalska I. Evaluation of lipid peroxidation and acid-base status in cord blood of newborns after diabetes in pregnancy. Przegl Lek 58: 120-123, 2001.
176. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, Zarzycki W, and Kinalska I. Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 33: 227-231, 2001.
177. Kinalski M, Sledziewski A, Telejko B, Zarzycki W, and Kinalska I. Lipid peroxidation and scavenging enzyme activity in streptozotocin-induced diabetes. Acta Diabetol 37: 179-183, 2000.
178. King GL and Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122: 333-338, 2004.
179. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, and Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51: 2207-2213, 2002.
180. Klein K, Satler M, Elhenicky M, Brix J, Krzyzanowska K, Schernthaner G, Husslein PW, and Schernthaner G-H. Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn 28: 845-851, 2008.
181. Knopp RH, Montes A, Childs M, Li JR, and Mabuchi H. Metabolic adjustments in normal and diabetic pregnancy. Clin Obstet Gynecol 24: 21-49, 1981.
182. Konishi H, Nakatsuka M, Chekir C, Noguchi S, Kamada Y, Sasaki A, and Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod 19: 2156-2162, 2004.
183. Kossenjans W, Eis A, Sahay R, Brockman D, and Myatt L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 278: H1311-H1319, 2000.
184. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 275: C1-C24, 1998.
185. Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52: 818-823, 2003.
186. Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL, Yajnik CS, and Fall CH. Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes. Diabetologia 52: 2350-2358, 2009.
187. Kroncke KD, Fehsel K, and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156, 1998.
188. Kukor Z, Valent S, and Toth M. Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. Placenta 21: 763-772, 2000.
189. Kumar SD, Dheen ST, and Tay SS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 6: 34, 2007.
190. Kurtz M, Capobianco E, Martinez N, Fernandez J, Higa R, White V, and Jawerbaum A. Carbaprostacyclin, a PPARdelta agonist, ameliorates excess lipid accumulation in diabetic rat placentas. Life Sci 86: 781-790, 2010.
191. Lachili B, Hininger I, Faure H, Arnaud J, Richard MJ, Favier A, and Roussel AM. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res 83: 103-110, 2001.
192. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, and Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 32: 121-127, 2011.
193. Langer O. Changing the diagnosis criteria of type 2 diabetes in pregnancy: do the ends justify the means? J Matern Fetal Neonatal Med 23: 234-238, 2010.
194. Langer O, Conway DL, Berkus MD, Xenakis EM, and Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343: 1134-1138, 2000.
195. Lao TT, Chan LY, Tam KF, and Ho LF. Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstet Gynecol 99: 807-812, 2002.
196. Lao TT, Chan PL, and Tam KF. Gestational diabetes mellitus in the last trimester-a feature of maternal iron excess? Diabet Med 18: 218-223, 2001.
197. Lao TT and Tam KF. Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 20: 1368-1369, 1997.
198. Lappas M, Mitton A, Lim R, Barker G, Riley C, and Permezel M. SIRT1 is a novel regulator of key pathways of human labor. Biol Reprod 84: 167-178, 2011.
199. Lappas M, Mitton A, and Permezel M. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J Endocrinol 204: 75-84, 2010.
200. Lappas M, Permezel M, Georgiou HM, and Rice GE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab 87: 4667-4672, 2002.
201. Lappas M, Permezel M, Ho PW, Moseley JM, Wlodek ME, and Rice GE. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. Placenta 25: 699-704, 2004.
202. Lappas M, Permezel M, and Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88: 1723-1729, 2003.
203. Lappas M, Permezel M, and Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 89: 5627-5633, 2004.
204. Lappas M, Permezel M, and Rice GE. 15-Deoxy-Delta( 12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta 27: 1060-1072, 2006.
205. Lappas M, Permezel M, and Rice GE. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Endocrinol 193: 269-277, 2007.
206. Lappas M, Riley C, Rice GE, and Permezel M. Increased expression of ac-FoxO1 protein in prelabor fetal membranes overlying the cervix: possible role in human fetal membrane rupture. Reprod Sci 16: 635-641, 2009.
207. Lappas M, Yee K, Permezel M, and Rice GE. Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta 27: 568-575, 2006.
208. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH, and Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085, 2010.
209. Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jorgensen T, Pedersen O, and Hansen T. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94: 145-150, 2009.
210. Lee QP and Juchau MR. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intraamniotic injections of sodium nitroprusside and NGmonomethyl-L-arginine. Teratology 49: 452-464, 1994.
211. Leitch I, Osmond D, Falconer J, Clifton V, Walters W, and Read M. Vasoactive effects of 8-epi-prostaglandin-F2alpha in the human placenta in vitro. J Soc Gynecol Invest 6: 195A, 1999.
212. Lesser KB and Carpenter MW. Metabolic changes associated with normal pregnancy and pregnancy complicated by diabetes mellitus. Semin Perinatol 18: 399-406, 1994.
213. Li H, Gu B, Zhang Y, Lewis DF, and Wang Y. Hypoxiainduced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 26: 210-217, 2005.
214. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. J Soc Gynecol Investig 13: 2-10, 2006.
215. Loh TT, Higuchi DA, van Bockxmeer FM, Smith CH, and Brown EB. Transferrin receptors on the human placental microvillous membrane. J Clin Invest 65: 1182-1191, 1980.
216. Loukovaara MJ, Loukovaara S, Leinonen PJ, Teramo KA, and Andersson SH. Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol 118: 160-165, 2005.
217. Loven A, Romem Y, Pelly IZ, Holcberg G, and Agam G. Copper metabolism-a factor in gestational diabetes? Clin Chim Acta 213: 51-59, 1992.
218. Lunghi L, Ferretti ME, Medici S, Biondi C, and Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol 5: 6, 2007.
219. Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, Xiong X, and Walker M. Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress? Med Hypotheses 66: 38-44, 2006.
220. Luoto R, Laitinen K, Nermes M, and Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 103: 1792-1799, 2010.
221. Lurie S, Matas Z, Boaz M, Fux A, Golan A, and Sadan O. Different degrees of fetal oxidative stress in elective and emergent cesarean section. Neonatology 92: 111-115, 2007.
222. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, and Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21: 1753-1758, 1998.
223. MacMicking J, Xie QW, and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350, 1997.
224. Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, and Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest 65: 227-232, 2008.
225. Maeda H, Okamoto T, and Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 379: 193-200, 1998.
226. Maggirwar SB, Dhanraj DN, Somani SM, and Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201: 508-515, 1994.
227. Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, Lambeth JD, and Goldstein BJ. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24: 1844-1854, 2004.
228. Mandang S, Manuelpillai U, and Wallace EM. Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol 192: 485-493, 2007.
229. Manea A, Tanase LI, Raicu M, and Simionescu M. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun 396: 901-907, 2010.
230. Mann GE, Rowlands DJ, Li FY, de Winter P, and Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 75: 261-274, 2007.
231. Maritim AC, Sanders RA, and Watkins JB, 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-38, 2003.
232. Matsubara S, Takizawa T, Suzuki T, Minakami H, and Sato I. Glucose-6-phosphate dehydrogenase is present in normal and pre-eclamptic placental trophoblasts: ultrastructural enzyme-histochemical evidence. Placenta 22: 90-95, 2001.
233. Mazzanti L, Nanetti L, Vignini A, Rabini RA, Grechi G, Cester N, Curzi CM, and Tranquilli AL. Gestational diabetes affects platelet behaviour through modified oxidative radical metabolism. Diabet Med 21: 68-72, 2004.
234. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, and Young IS. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 376: 259-266, 2010.
235. Medalie JH, Papier CM, Goldbourt U, and Herman JB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135: 811-817, 1975.
236. Melamed N, Chen R, Soiberman U, Ben-Haroush A, Hod M, and Yogev Y. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors. Arch Gynecol Obstet 278: 129-134, 2008.
237. Metzger BE, Phelps RL, Freinkel N, and Navickas IA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 3: 402-409, 1980.
238. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CNA, Plutzky J, Reddy JK, Spiegelman BM, Staels B, and Wahli W. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58: 726-741, 2006.
239. Milczarek R, Klimek J, and Zelewski L. The effects of ascorbate and alpha-tocopherol on the NADPH-dependent lipid peroxidation in human placental mitochondria. Mol Cell Biochem 210: 65-73, 2000.
240. Milner RD and Hill DJ. Fetal growth control: the role of insulin and related peptides. Clin Endocrinol (Oxf) 21: 415-433, 1984.
241. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, and Jacobs DR, Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85: 895-909, 2007.
242. Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab 36: 617-627, 2010.
243. Mittermayer F, Mayer BX, Meyer A, Winzer C, Pacini G, Wagner OF, Wolzt M, and Kautzky-Willer A. Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes. Diabetologia 45: 1372-1378, 2002.
244. Moellering D, Mc Andrew J, Patel RP, Forman HJ, Mulcahy RT, Jo H, and Darley-Usmar VM. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett 448: 292-296, 1999.
245. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 12: 78-82, 2001.
246. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
247. Montalbetti N, Cantero MR, Dalghi MG, and Cantiello HF. Reactive oxygen species inhibit polycystin-2 (TRPP2) cation channel activity in term human syncytiotrophoblast. Placenta 29: 510-518, 2008.
248. Morgan SC, Relaix F, Sandell LL, and Loeken MR. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res A Clin Mol Teratol 82: 453-463, 2008.
249. Murad F, Mittal CK, Arnold WP, Katsuki S, and Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 9: 145-158, 1978.
250. Mustafa S, Vukovich T, Prikoszovich T, Winzer C, Schneider B, Esterbauer H, Wagner O, and Kautzky-Willer A. Haptoglobin phenotype and gestational diabetes. Diabetes Care 27: 2103-2107, 2004.
251. Myatt L. Placental adaptive responses and fetal programming. J Physiol 572: 25-30, 2006.
252. Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31 Suppl: S66-S69, 2010.
253. Myatt L and Cui X. Oxidative stress in the placenta. Histochem Cell Biol 122: 369-382, 2004.
254. Nagareddy PR, Soliman H, Lin G, Rajput PS, Kumar U, McNeill JH, and MacLeod KM. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthasemediated cardiovascular abnormalities in streptozotocininduced diabetic rats. Diabetes 58: 2355-2364, 2009.
255. Navarro A, Alonso A, Garrido P, Gonzalez C, del Rey CG, Ordonez C, and Tolivia J. Increase in placental apolipoprotein D as an adaptation to human gestational diabetes. Placenta 31: 25-31, 2010.
256. Neerhof MG, Synowiec S, Khan S, and Thaete LG. Pathophysiology of chronic nitric oxide synthase inhibitioninduced fetal growth restriction in the rat. Hypertens Pregnancy 30: 28-36, 2011.
257. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
258. Nolan CJ and Proietto J. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37: 976-984, 1994.
259. Norwitz ER, Schust DJ, and Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 345: 1400-1408, 2001.
260. Novaro V, Gonzalez E, Jawerbaum A, Rettori V, Canteros G, and Gimeno MF. Nitric oxide synthase regulation during embryonic implantation. Reprod Fertil Dev 9: 557-564, 1997.
261. Novaro V, Jawerbaum A, Faletti A, Gimeno MA, and Gonzalez ET. Uterine nitric oxide and prostaglandin E during embryonic implantation in non-insulin-dependent diabetic rats. Reprod Fertil Dev 10: 217-223, 1998.
262. Novaro V, Pustovrh C, Colman-Lerner A, Radisky D, Lo Nostro F, Paz D, Jawerbaum A, and Gonzalez E. Nitric oxide induces gelatinase A (matrix metalloproteinase 2) during rat embryo implantation. Fertil Steril 78: 1278-1287, 2002.
263. Oettl K and Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151: 580-590, 2007.
264. Okazaki T, Otani H, Shimazu T, Yoshioka K, Fujita M, Katano T, Ito S, and Iwasaka T. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/ reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol 50: 534-544, 2011.
265. Okuno S, Akazawa S, Yasuhi I, Kawasaki E, Matsumoto K, Yamasaki H, Matsuo H, Yamaguchi Y, and Nagataki S. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res 27: 231-234, 1995.
266. Onozato ML, Tojo A, Goto A, and Fujita T. Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. Kidney Int 65: 951-960, 2004.
267. Orhan H, Onderoglu L, Yucel A, and Sahin G. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267: 189-195, 2003.
268. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 24: 31-41, 2007.
269. Ornoy A, Tsadok MA, Yaffe P, and Zangen SW. The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reprod Toxicol 28: 521-529, 2009.
270. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
271. Pacher P, Obrosova IG, Mabley JG, and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12: 267-275, 2005.
272. Pavan L, Hermouet A, Tsatsaris V, Therond P, Sawamura T, Evain-Brion D, and Fournier T. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145: 4583-4591, 2004.
273. Pertynska-Marczewska M, Glowacka E, Sobczak M, Cypryk K, and Wilczynski J. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol 61: 175-182, 2009.
274. Pessler D, Rudich A, and Bashan N. Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia 44: 2156-2164, 2001.
275. Petraglia F, Devita D, Gallinelli A, Aguzzoli L, Genazzani AR, Romero R, and Woodruff TK. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 80: 558-561, 1995.
276. Peuchant E, Brun JL, Rigalleau V, Dubourg L, Thomas MJ, Daniel JY, Leng JJ, and Gin H. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 37: 293-298, 2004.
277. Peunova N and Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73, 1995.
278. Pinkney JH, Stehouwer CD, Coppack SW, and Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46 Suppl 2: S9-S13, 1997.
279. Plachta N, Traister A, and Weil M. Nitric oxide is involved in establishing the balance between cell cycle progression and cell death in the developing neural tube. Exp Cell Res 288: 354-362, 2003.
280. Poston L and Raijmakers MT. Trophoblast oxidative stress, antioxidants and pregnancy outcome-a review. Placenta 25 Suppl A: S72-S78, 2004.
281. Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med 26: 299-312, 2005.
282. Pustovrh C, Jawerbaum A, Sinner D, Pesaresi M, Baier M, Micone P, Gimeno M, and Gonzalez ET. Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev 12: 269-275, 2000.
283. Pustovrh MC, Capobianco E, Martinez N, Higa R, White V, and Jawerbaum A. MMP/TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. Eur J Clin Invest 39: 1082-1090, 2009.
284. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Lopez-Costa JJ, and Gonzalez E. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta 26: 339-348, 2005.
285. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Martinez N, Lopez-Costa JJ, and Gonzalez E. Oxidative stress promotes the increase of matrix metalloproteinases-2 and-9 activities in the feto-placental unit of diabetic rats. Free Radic Res 39: 1285-1293, 2005.
286. Pustovrh MC, Jawerbaum A, White V, Capobianco E, Higa R, Martinez N, Lopez-Costa JJ, and Gonzalez E. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Reproduction 134: 605-613, 2007.
287. Radaelli T, Varastehpour A, Catalano P, and Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52: 2951-3958, 2003.
288. Rahman A, Kefer J, Bando M, Niles WD, and Malik AB. Eselectin expression in human endothelial cells by TNF-alphainduced oxidant generation and NF-kappa B activation. Am J Physiol Lung Cell Mol Physiol 275: L533-L544, 1998.
289. Rajapakse AG, Ming XF, Carvas JM, and Yang Z. The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. Am J Physiol Heart Circ Physiol 296: H815-H822, 2009.
290. Rajdl D, Racek J, Steinerova A, Novotny Z, Stozicky F, Trefil L, and Siala K. Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res 54: 429-436, 2005.
291. Rajesh M, Mukhopadhyay P, Batkai S, Mukhopadhyay B, Patel V, Hasko G, Szabo C, Mabley JG, Liaudet L, and Pacher P. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 13: 2330-2341, 2009.
292. Raza H and John A. Glutathione metabolism and oxidative stress in neonatal rat tissues from streptozotocin-induced diabetic mothers. Diabetes Metab Res Rev 20: 72-78, 2004.
293. Read MA, Boura AL, and Walters WA. Vascular actions of purines in the foetal circulation of the human placenta. Br J Pharmacol 110: 454-460, 1993.
294. Reti NG, Lappas M, Riley C, Wlodek ME, Permezel M, Walker S, and Rice GE. Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes. Am J Obstet Gynecol 196: 484.e1-10, 2007.
295. Roberts VHJ, Smith J, Mclea SA, Heizer AB, Richardson JL, and Myatt L (Eds). Effect of Increasing Maternal Body Mass Index on Oxidative and Nitrative Stress in the Human Placenta. Oxford, ROYAUME-UNI: Elsevier, 2009, p. 7
296. Rocha SO, Gomes GN, Forti AL, do Carmo Pinho Franco M, Fortes ZB, de Fatima Cavanal M, and Gil FZ. Long-term effects of maternal diabetes on vascular reactivity and renal function in rat male offspring. Pediatr Res 58: 1274-1279, 2005.
297. Rolo AP and Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212: 167-178, 2006.
298. Rosenfeld CR, Cox BE, Roy T, and Magness RR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest 98: 2158-2166, 1996.
299. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, and Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite- dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269: 26066-26075, 1994.
300. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, and Sturis J. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44: 506-512, 1995.
301. Ryu S, Kohen R, Samuni A, and Ornoy A. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage. Birth Defects Res A Clin Mol Teratol 79: 604-611, 2007.
302. San Martin R and Sobrevia L. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27: 1-10, 2006.
303. Sanders TH, McMichael RW, Jr., and Hendrix KW. Occurrence of resveratrol in edible peanuts. J Agric Food Chem 48: 1243-1246, 2000.
304. Sankaralingam S, Xu Y, Sawamura T, and Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension 53: 270-277, 2009.
305. Santra D, Sawhney H, Aggarwal N, Majumdar S, and Vasishta K. Lipid peroxidation and vitamin E status in gestational diabetes mellitus. J Obstet Gynaecol Res 29: 300-304, 2003.
306. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, and Herrera E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31: 1858-1863, 2008.
307. Schmid E, Hotz-Wagenblatt A, Hacj V, and Droge W. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming. FASEB J 13: 1491-1500, 1999.
308. Schonfelder G, John M, Hopp H, Fuhr N, van Der Giet M, and Paul M. Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10: 777-784, 1996.
309. Sengupta J, Dhawan L, Lalitkumar PG, and Ghosh D. Nitric oxide in blastocyst implantation in the rhesus monkey. Reproduction 130: 321-332, 2005.
310. Sgarbosa F, Barbisan LF, Brasil MA, Costa E, Calderon IM, Goncalves CR, Bevilacqua E, and Rudge MV. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract 73: 143-149, 2006.
311. Shaat N, Karlsson E, Lernmark A, Ivarsson S, Lynch K, Parikh H, Almgren P, Berntorp K, and Groop L. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 49: 1545-1551, 2006.
312. Shakibaei M, Harikumar KB, and Aggarwal BB. Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53: 115-128, 2009.
313. Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, and Friedman JE. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes 49: 603-610, 2000.
314. Sidorkina O, Espey MG, Miranda KM, Wink DA, and Laval J. Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic Biol Med 35: 1431-1438, 2003.
315. Siman CM and Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46: 1054-1061, 1997.
316. Simpson JL, Elias S, Martin AO, Palmer MS, Ogata ES, and Radvany RA. Diabetes in pregnancy, Northwestern University series (1977-1981). I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 146: 263-270, 1983.
317. Sivan E, Homko CJ, Whittaker PG, Reece EA, Chen X, and Boden G. Free fatty acids and insulin resistance during pregnancy. J Clin Endocrinol Metab 83: 2338-2342, 1998.
318. Sivan E, Lee YC, Wu YK, and Reece EA. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56: 343-349, 1997.
319. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, and Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175: 793-799, 1996.
320. Soares DG, Andreazza AC, and Salvador M. Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem 51: 1077-1080, 2003.
321. Sobki SH, Al-Senaidy AM, Al-Shammari TA, Inam SS, Al-Gwiser AA, and Bukhari SA. Impact of gestational diabetes on lipid profiling and indices of oxidative stress in maternal and cord plasma. Saudi Med J 25: 876-880, 2004.
322. Sobrevia L, Abarzua F, Nien JK, Salomon C, Westermeier F, Puebla C, Cifuentes F, Guzman-Gutierrez E, Leiva A, and Casanello P. Review: differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 32 Suppl 2: S159-S164, 2011.
323. Sobrevia L, Cesare P, Yudilevich DL, and Mann GE. Diabetes-induced activation of system y + and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 489 (Pt 1): 183-192, 1995.
324. Sobrevia L, Yudilevich DL, and Mann GE. Elevated Dglucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies. J Physiol 506 (Pt 1): 219-230, 1998.
325. Soubasi V, Petridou S, Sarafidis K, Tsantali C, Diamanti E, Buonocore G, and Drossou-Agakidou V. Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation. Diabetes Metab 36: 58-63, 2010.
326. Sparks SP, Jovanovic-Peterson L, and Peterson CM. Blood glucose rise following prenatal vitamins in gestational diabetes. J Am Coll Nutr 12: 543-546, 1993.
327. Stanley JL, Sankaralingam S, Baker PN, and Davidge ST. Previous gestational diabetes impairs long-term endothelial function in a mouse model of complicated pregnancy. Am J Physiol Regul Integr Comp Physiol 299: R862-R870, 2010.
328. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 101: 14D-19D, 2008.
329. Sugimura Y, Murase T, Oyama K, Uchida A, Sato N, Hayasaka S, Kano Y, Takagishi Y, Hayashi Y, Oiso Y, and Murata Y. Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes. Diabetologia 52: 962-971, 2009.
330. Surapaneni KM and Vishnu Priya V. Antioxidant enzymes and vitamins in gestational diabetes. J Clin Diagn Res 2: 1081-1085, 2008.
331. This reference has been deleted.
332. Suzuki T, Nagamatsu C, Kushima T, Miyakoshi R, Tanaka K, Morita H, Sakaue M, and Takizawa T. Apoptosis caused by an inhibitor of NO production in the decidua of rat from mid-gestation. Exp Biol Med (Maywood) 235: 455-462, 2010.
333. Szeto IMY, Aziz A, Das PJ, Taha AY, Okubo N, Reza-Lopez S, Giacca A, and Anderson GH. High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring. Am J Physiol Regul Integr Comp Physiol 295: R575-R582, 2008.
334. Tain YL, Hsieh CS, Lin IC, Chen CC, Sheen JM, and Huang LT. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 23: 34-41, 2010.
335. Tan M, Sheng L, Qian Y, Ge Y, Wang Y, Zhang H, Jiang M, and Zhang G. Changes of serum selenium in pregnant women with gestational diabetes mellitus. Biol Trace Elem Res 83: 231-237, 2001.
336. Tarim E, Yigit F, Kilicdag E, Bagis T, Demircan S, Simsek E, Haydardedeoglu B, and Yanik F. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 27: 177-182, 2006.
337. Terao J. Dietary flavonoids as antioxidants. Forum Nutr 61: 87-94, 2009.
338. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, and Karumanchi SA. First-trimester follistatinlike-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care 33: 664-669, 2010.
339. Thaler CD and Epel D. Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: a little dab'll do ya. Curr Pharm Des 9: 399-409, 2003.
340. Thomas SR, Chen K, and Keaney JF, Jr. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal 5: 181-194, 2003.
341. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, and Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666-674, 2007.
342. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, and Dunne F. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond) 106: 93-98, 2004.
343. Topel I, Stanarius A, and Wolf G. Distribution of the endothelial constitutive nitric oxide synthase in the developing rat brain: an immunohistochemical study. Brain Res 788: 43-48, 1998.
344. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, and Valente O. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 10: 194-203, 2009.
345. Umekawa T, Sugiyama T, Kihira T, Murabayashi N, Zhang L, Nagao K, Kamimoto Y, Ma N, Yodoi J, and Sagawa N. Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism. Endocrinology 149: 3980-3988, 2008.
346. Vaisanen-Tommiska MR. Nitric oxide in the human uterine cervix: endogenous ripening factor. AnnMed 40: 45-55, 2008.
347. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, and Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 7: 79, 2009.
348. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
349. Van Assche FA, De Prins F, Aerts L, and Verjans M. The endocrine pancreas in small-for-dates infants. Br J Obstet Gynaecol 84: 751-753, 1977.
350. Vasquez G, Sanhueza F, Vasquez R, Gonzalez M, San Martin R, Casanello P, and Sobrevia L. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 560: 111-122, 2004.
351. Viana M, Aruoma OI, Herrera E, and Bonet B. Oxidative damage in pregnant diabetic rats and their embryos. Free Radic Biol Med 29: 1115-1121, 2000.
352. Viana M, Castro M, Barbas C, Herrera E, and Bonet B. Effect of different doses of vitamin E on the incidence of malformations in pregnant diabetic rats. Ann Nutr Metab 47: 6-10, 2003.
353. von Mandach U, Lauth D, and Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. J Matern Fetal Neonatal Med 13: 22-27, 2003.
354. Vonnahme KA, Wilson ME, Li Y, Rupnow HL, Phernetton TM, Ford SP, and Magness RR. Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. J Physiol 565: 101-109, 2005.
355. Wang Y, Tan M, Huang Z, Sheng L, Ge Y, Zhang H, Jiang M, and Zhang G. Elemental contents in serum of pregnant women with gestational diabetes mellitus. Biol Trace Elem Res 88: 113-118, 2002.
356. Wang Y and Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 22: 206-212, 2001.
357. Weiss U, Cervar M, Puerstner P, Schmut O, Haas J, Mauschitz R, Arikan G, and Desoye G. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia 44: 209-219, 2001.
358. Weksler-Zangen S, Yaffe P, and Ornoy A. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res A Clin Mol Teratol 67: 429-437, 2003.
359. Wentzel P, EjdesjöA, and Eriksson UJ. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 52: 1222-1228, 2003.
360. Wentzel P and Eriksson UJ. 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro. Teratology 66: 164-168, 2002.
361. Wentzel P, Gareskog M, and Eriksson UJ. Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats. Diabetes 57: 3344-3352, 2008.
362. Wentzel P, Welsh N, and Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 48: 813-820, 1999.
363. Westermeier F, Puebla C, Vega JL, Farias M, Escudero C, Casanello P, and Sobrevia L. Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol 7: 435-449, 2009.
364. Westermeier F, Salomon C, Gonzalez M, Puebla C, Guzman-Gutierrez E, Cifuentes F, Leiva A, Casanello P, and Sobrevia L. Insulin restores gestational diabetes mellitusreduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes 60: 1677-1687, 2011.
365. White V, Capobianco E, Higa R, Martinez N, Sosa M, Pustovrh MC, and Jawerbaum A. Increased nitration and diminished activity of copper/zinc superoxide dismutase in placentas from diabetic rats. Free Radic Res 44: 1407-1415, 2010.
366. White V, Gonzalez E, Capobianco E, Pustovrh C, Martinez N, Higa R, Baier M, and Jawerbaum A. Leptin modulates nitric oxide production and lipid metabolism in human placenta. Reprod Fertil Dev 18: 425-432, 2006.
367. White V, Gonzalez E, Pustovrh C, Capobianco E, Martinez N, Do Porto DF, Higa R, and Jawerbaum A. Leptin in embryos from control and diabetic rats during organogenesis: a modulator of nitric oxide production and lipid homeostasis. Diabetes Metab Res Rev 23: 580-588, 2007.
368. White V, Jawerbaum A, Sinner D, Pustovrh C, Capobianco E, and Gonzalez E. Oxidative stress and altered prostanoid production in the placenta of streptozotocin-induced diabetic rats. Reprod Fertil Dev 14: 117-123, 2002.
369. Whitley GS and Cartwright JE. Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta 31: 465-474, 2010.
370. Wieser F, Waite L, Depoix C, and Taylor RN. PPAR action in human placental development and pregnancy and its complications. PPAR Res 2008: 527048, 2008.
371. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, and Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 3: 203-213, 2001.
372. Wiznitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece EA, Trischler H, and Bashan N. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocininduced diabetes. Am J Obstet Gynecol 180: 188-193, 1999.
373. Xia L, Wang H, Munk S, Kwan J, Goldberg HJ, Fantus IG, and Whiteside CI. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol 295: F1705-F1714, 2008.
374. Xia Y. Superoxide generation from nitric oxide synthases. Antioxid Redox Signal 9: 1773-1778, 2007.
375. Xing AY, Challier JC, Lepercq J, Cauzac M, Charron MJ, Girard J, and Hauguel-de Mouzon S. Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. J Clin Endocrinol Metab 83: 4097-4101, 1998.
376. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, and Thornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57: 2809-2817, 2008.
377. Yallampalli C and Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169: 1316-1320, 1993.
378. Yang P, Cao Y, and Li H. Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation. Am J Obstet Gynecol 203: 185.e5-11, 2010.
379. Yessoufou A, Soulaimann N, Merzouk SA, Moutairou K, Ahissou H, Prost J, Simonin AM, Merzouk H, Hichami A, and Khan NA. N-3 Fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond) 30: 739-750, 2006.
380. Young SL, Evans K, and Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 282: L379-L385, 2002.
381. Yu T, Robotham JL, and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103: 2653-2658, 2006.
382. Yu Y, Singh U, Shi W, Konno T, Soares MJ, Geyer R, and Fundele R. Influence of murine maternal diabetes on placental morphology, gene expression, and function. Arch Physiol Biochem 114: 99-110, 2008.
383. Yuan B, Ohyama K, Takeichi M, and Toyoda H. Direct contribution of inducible nitric oxide synthase expression to apoptosis induction in primary smooth chorion trophoblast cells of human fetal membrane tissues. Int J Biochem Cell Biol 41: 1062-1069, 2009.
384. Zabihi S, Eriksson UJ, and Wentzel P. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod Toxicol 23: 486-498, 2007.
385. Zabihi S, Wentzel P, and Eriksson UJ. Altered uterine perfusion is involved in fetal outcome of diabetic rats. Placenta 29: 413-421, 2008.
386. Zangen SW, Yaffe P, Shechtman S, Zangen DH, and Ornoy A. The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats. Int J Exp Diabetes Res 3: 247-255, 2002.
387. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostrom KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C, Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU, Jorgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF, Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N, Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A, Shields B, Sjogren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorleifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker M, Watanabe RM, Weedon MN, Willer CJ, Illig T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L, McCarthy MI, Boehnke M, and Altshuler D. Meta-analysis of genomewide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645, 2008.
388. Zhang DX and Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 292: H2023-H2031, 2007.
389. Zhang H, Zhang J, Ungvari Z, and Zhang C. Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29: 1164-1171, 2009.